These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4040205)

  • 1. Cisplatin and cytarabine administered intrapleurally as treatment of malignant pleural effusions.
    Markman M; Cleary S; King ME; Howell SB
    Med Pediatr Oncol; 1985; 13(4):191-3. PubMed ID: 4040205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
    Rusch VW; Figlin R; Godwin D; Piantadosi S
    J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cisplatin and cytosine arabinoside (ARA-C) for the therapy of primary and secondary pleural neoplasms].
    Aitini E; Cavazzini G; Cantore M; Rabbi C; Smerieri F
    G Ital Oncol; 1990; 10(3):85-8. PubMed ID: 2286397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapleural chemotherapy without pleurodesis for malignant pleural effusions. LCSG Trial 861.
    Figlin R; Mendoza E; Piantadosi S; Rusch V
    Chest; 1994 Dec; 106(6 Suppl):363S-366S. PubMed ID: 7988265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions.
    Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK
    Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination intracavitary chemotherapy for malignant pleural disease.
    Markman M; Howell SB; Green MR
    Cancer Drug Deliv; 1984; 1(4):333-6. PubMed ID: 6544129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal management of malignant mesothelioma after subtotal pleurectomy: revisiting the role of intrapleural chemotherapy and postoperative radiation.
    Sauter ER; Langer C; Coia LR; Goldberg M; Keller SM
    J Surg Oncol; 1995 Oct; 60(2):100-5. PubMed ID: 7564374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboplatin and cisplatin pharmacokinetics after intrapleural combination treatment in patients with malignant pleural effusion.
    Lerza R; Vannozzi MO; Tolino G; Viale M; Bottino GB; Bogliolo G; Cerruti A; Castello G; Mencoboni M; Reggiardo G; Pannacciulli I; Esposito M
    Ann Oncol; 1997 Apr; 8(4):385-91. PubMed ID: 9209670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intrapleural cisplatin for the treatment of malignant pleural effusions.
    Monjanel-Mouterde S; Frenay C; Catalin J; Boutin C; Durand A; Astoul P
    Oncol Rep; 2000; 7(1):171-5. PubMed ID: 10601613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
    Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
    J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma: a phase II FONICAP trial. Italian Lung Cancer Task Force.
    Pennucci MC; Ardizzoni A; Pronzato P; Fioretti M; Lanfranco C; Verna A; Giorgi G; Vigani A; Frola C; Rosso R
    Cancer; 1997 May; 79(10):1897-902. PubMed ID: 9149015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of successful intrapleural chemotherapy with Cisplatin plus cytarabine for intractable malignant pleural effusion.
    Moon YW; Choi ST; Cho BC; Choi HJ; Kim YT
    Yonsei Med J; 2007 Dec; 48(6):1035-8. PubMed ID: 18159598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bio-adhesio-chemo (BAC) therapy for patients with malignant pleural effusion.
    Sugitachi A; Takatsuka Y; Kido T; Miyaji N; Satoh E
    Am J Clin Oncol; 1989 Apr; 12(2):156-61. PubMed ID: 2705406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity.
    Markman M; Howell SB; Lucas WE; Pfeifle CE; Green MR
    J Clin Oncol; 1984 Dec; 2(12):1321-6. PubMed ID: 6542584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of remission in diffuse pleural mesothelioma induced by anticancer chemotherapy with cisplatin and adriamycin].
    Kinoshita S; Yamashita T; Yagi M; Bando H; Tsubura E; Sano T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1872-6. PubMed ID: 4041164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity.
    Markman M; Cleary S; Lucas WE; Howell SB
    J Clin Oncol; 1985 Jul; 3(7):925-31. PubMed ID: 3894586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycin.
    Markman M; Cleary S; Lucas W; Weiss R; Howell SB
    Cancer Treat Rep; 1986 Jun; 70(6):755-60. PubMed ID: 2425962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
    Rusch V; Saltz L; Venkatraman E; Ginsberg R; McCormack P; Burt M; Markman M; Kelsen D
    J Clin Oncol; 1994 Jun; 12(6):1156-63. PubMed ID: 8201377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Loco-regional cancer chemotherapy in patients with malignant pleural effusion--improving the QOL of patients].
    Sugitachi A; Kawahara T; Kido T; Shindoh T; Sakamoto I
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1583-7. PubMed ID: 2389952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
    Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
    Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.